Structure |
Chemical Name |
CAS |
MF |
 |
SalMeterol EP IMpurity D |
1391052-04-2 |
C34H47NO7 |
 |
3-Pyridinecarboxylic Acid 2-AMinoethyl Ester Dihydrochloride |
87330-70-9 |
C8H11ClN2O2 |
 |
PeMetrexed EP IMpurity D |
144051-68-3 |
C25H28N6O9 |
 |
SuMatriptan EP IMpurity F |
2074615-63-5 |
C13H17N3O2S |
 |
Perindopril Impurity |
|
|
 |
Ganciclovir Dipropionate |
86357-20-2 |
C15H21N5O6 |
 |
IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide |
39084-88-3 |
C10H11Cl2NO |
 |
1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione |
61919-52-6 |
C20H26O3 |
 |
5-Fluoro ent-LaMivudine Acid D-Menthol Ester |
764659-79-2 |
C18H26FN3O4S |
![Tricyclo[3.3.1.13,7]decan-1-aMine, 3,5,7-triMethyl-, hydrochloride](/CAS/20150408/GIF/15210-60-3.gif) |
Tricyclo[3.3.1.13,7]decan-1-aMine, 3,5,7-triMethyl-, hydrochloride |
15210-60-3 |
C13H24ClN |
 |
3-((butyryloxy)Methyl) 5-Methyl 4-(2',3'-dichlorophenyl)-2,6-diMethylpyridine-3,5-dicarboxylate |
188649-48-1 |
C21H21Cl2NO6 |
 |
Bis Valacyclovir (~90%) |
1356019-51-6 |
C27H40N12O8 |
 |
Flupirtine DiMer |
1417916-52-9 |
C30H32F2N8O4 |
 |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
2304623-36-5 |
C16H14N2O3S |
 |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(M-tolyl)propan-1-aMine |
253337-60-9 |
C22H25N |
![3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide](/CAS/20150408/GIF/CB42666835.gif) |
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide |
1675248-19-7 |
C16H22N6O2 |
 |
Blonanserin iMpurity |
132810-83-4 |
C23H30FN3 |
 |
Deferasirox iMpurity |
1688656-83-8 |
C42H28N6O8S |
 |
Lercanidipine iMpurity |
320750-19-4 |
C37H43N3O6 |
 |
AMpicillin EP IMpurity J |
6489-58-3 |
C13H20N2O4S |
 |
CefathiaMidine Lactone |
905712-22-3 |
C17H24N4O4S2 |
 |
Cinacalcet IMpurity 9 |
802918-36-1 |
C22H24F3N |
 |
Doxorubicin IMpurity B |
106401-68-7 |
C29H34BrNO11 |
 |
EzetiMibe IMpurity B |
|
|
![Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one]](/CAS/20150408/GIF/CB42674319.gif) |
Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one] |
1449785-88-9 |
C10H7F2N3O |
 |
HydroxyMethylidene thione |
1320360-86-8 |
C15H18N4OS |
 |
Lansoprazole IMpurity I |
|
|
 |
Lapatinib IMpurity 10 |
1152131-73-1 |
C26H17ClFN3O4 |
 |
Metronidazole IMpurity D |
|
|
 |
PraMipexole IMpurity V (PraMipexole IMpurity Z) |
|
|
 |
Prasugrel Acetyl IMpurity |
1443034-67-0 |
C18H18FNO3S |
 |
Propofol IMpurity G |
|
|
 |
SalMeterol IMpurity A |
|
C25H37NO4 |
 |
Sitagliptin Defuoro IMpurity 3 |
851307-12-5 |
C15H19F2NO4 |
 |
Sitagliptin N-Boc IMpurity |
486460-23-5 |
C21H23F6N5O3 |
 |
SulbactaM IMpurity D |
|
|
 |
Valsartan N2-Trityl IMpurity |
|
|
 |
Vardenafil IMpurity 3 |
1255919-01-7 |
C26H30N6O4S |
 |
Montelukast Cyclopropaneacetonitrile |
866923-62-8 |
C35H35ClN2OS |
 |
(3R,4R,5R,6S)-2-(acetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
461432-24-6 |
C22H27ClO7 |
 |
Ezetimibe Impurity |
1510820-22-0 |
C24H23F2NO2 |
 |
10,13-bissidechainpaclitaxel |
|
|
 |
Istradefylline Impurity A |
|
|
 |
(3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride |
|
C14H24Cl2N2 |
![2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole](/CAS/20150408/GIF/142384-07-4.gif) |
2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole |
142384-07-4 |
C14H12N4O3S |
 |
Valsartan Desvaleryl Impurity |
676129-92-3 |
C19H21N5O2 |
 |
Istradefylline iMpurity |
|
|
 |
(E)-Olopatadine Hydrochloride |
949141-22-4 |
C21H24ClNO3 |
![(3R,4R,5R)-3-(1-Ethylpropoxy)-4-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester](/CAS/GIF/204254-92-2.gif) |
(3R,4R,5R)-3-(1-Ethylpropoxy)-4-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester |
204254-92-2 |
C15H26O7S |
 |
8-Hydroxy Pitavastatin |
224320-09-6 |
C25H24FNO5 |
 |
Aloin Peracetate |
64951-96-8 |
C37H38O17 |
![L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester](/CAS/20150408/GIF/1256490-52-4.gif) |
L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester |
1256490-52-4 |
C18H17F5NO5P |
 |
Cefditoren iMpurity 2, Cefditoren open ring |
|
|
 |
Ceftriaxone IMpurity C |
|
|
 |
Etoricoxib iMpurity 2 |
|
|
 |
Lorcaserin iMpurity D |
1030624-36-2 |
C11H14ClNO2 |
 |
Ticagrelor IMpurity L (Mixture of DiastereoMers) |
|
|
![α-Hydroxy-α-3-thienyl-2-thiopheneacetic Acid 9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester](/CAS/20180808/GIF/783273-13-2.gif) |
α-Hydroxy-α-3-thienyl-2-thiopheneacetic Acid 9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester |
783273-13-2 |
C18H19NO4S2 |
![3H-4,7a-Methanocyclohept[3,3a]indeno[5,4-b]oxete Benzenepropanoic Acid Derivative](/CAS/20150408/GIF/146139-03-9.gif) |
3H-4,7a-Methanocyclohept[3,3a]indeno[5,4-b]oxete Benzenepropanoic Acid Derivative |
146139-03-9 |
C47H51NO14 |
 |
Fluvastatin 3-Hydroxy-4,6-diene |
1207963-21-0 |
C24H24FNO3 |
 |
Cyclosporine iMpurity |
|
|
 |
ThiaMine IMpurity |
|
C12H17ClN4OS |
 |
CitalopraM IMpurity |
|
|
 |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
|
C16H14N2O3S |
 |
Tigecycline |
|
|
 |
1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
1496551-72-4 |
C10H13ClN2O5 |
![1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)-](/CAS/20180808/GIF/1020414-33-8.gif) |
1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)- |
1020414-33-8 |
C22H25ClF3N |
 |
4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine |
1823431-32-8 |
C7H9Cl2N3OS |
![Acetic acid, [[(3aR,4S,6R,6aS)-tetrahydro-2,2-diMethyl-6-[[(phenylMethoxy)carbonyl]aMino]-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester](/CAS/20150408/GIF/866551-95-3.gif) |
Acetic acid, [[(3aR,4S,6R,6aS)-tetrahydro-2,2-diMethyl-6-[[(phenylMethoxy)carbonyl]aMino]-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester |
866551-95-3 |
C20H27NO7 |
 |
4',6'-Dinitro-2'-phenoxymethanesulfonanilide |
51765-56-1 |
C13H11N3O7S |
![5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride](/CAS/20150408/GIF/33778-93-7.gif) |
5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride |
33778-93-7 |
C20H26ClNO4 |
 |
Blonanserin Impurity I |
|
|
 |
25,26,26,26,27,27-hexadeuterocholest-5-ene-3,27-diol |
1246302-95-3 |
C27H40D6O2 |
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](/CAS/20200611/GIF/1564265-95-7.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-95-7 |
C18H25N3O2 |
![(1S,5R,6R)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester](/CAS/20150408/GIF/876014-27-6.gif) |
(1S,5R,6R)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester |
876014-27-6 |
C9H12O4 |
 |
(3R,5R)-Rosuvastatin Lactone |
1422954-11-7 |
C22H26FN3O5S |
 |
(S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine |
1867177-06-7 |
C9H13N3OS |
 |
EMpagliflozin iMpurity 10 |
2069942-68-1 |
C32H37ClO12 |
 |
EMpagliflozin iMpurity 15 |
|
|
 |
(S)-8-(3-aMinopiperidin-1-yl)-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione |
668269-51-0 |
C25H28N8O2 |
 |
ibrutinib iMpurity B |
|
|
 |
Sunitinib iMpurity A |
|
|
 |
Sunitinib iMpurity F |
|
|
 |
(3R,4S)-1-(3-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-06-5 |
C24H21F2NO3 |
 |
Betamethasone EP Impurity J |
18383-24-9 |
C22H30O4 |
 |
Cefazedone Related Impurity 10 |
18884-65-6 |
C10H12N2O5S |
 |
Etoricoxib Impurity 8 |
1421227-97-5 |
C22H20N2O4S |
 |
Mupirocin Impurity E |
|
C26H44O9 |
 |
Phenylephrine Impurity 1 |
|
C9H13NO2 |
 |
Rupatadine Impurity B |
156523-04-5 |
C26H24ClN3O |
 |
Theophylline Impurity 1 |
5614-53-9 |
C9H10N4O3 |
 |
Venlafaxine N-Dimer |
1187545-61-4 |
C32H48N2O4 |
 |
ent-Ivabradine Hydrochloride |
148849-68-7 |
C27H37ClN2O5 |
 |
Sofosbuvir metabolites GS566500 |
1233335-78-8 |
C13H19FN3O9P |
 |
Ondansetron impurity G (PhEur) |
99614-04-7 |
C17H18ClN3O |
 |
4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester |
1421312-34-6 |
C18H15NO4 |
![2-[(4-METHYLPHENOXY)METHYL]BENZOIC ACID](/StructureFile/ChemBookStructure3/GIF/CB4281380.gif) |
2-[(4-METHYLPHENOXY)METHYL]BENZOIC ACID |
728-97-2 |
C15H14O3 |
 |
Ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- (1-ethylpropoxy)cyclohexanecarboxylate |
2124269-41-4 |
C16H29N5O4 |
 |
2-AMINO-3,5-DIBROMOBENZENE-1-CARBOHYDRAZIDE |
97096-13-4 |
C7H7Br2N3O |
 |
Trityl losartan |
133909-99-6 |
C41H37ClN6O |